FDA inspection
Amphastar France Pharmaceuticals: FDA inspection ending Oct 20, 2009
FDA inspection 625848 · No Action Indicated (NAI) · Eragny Sur Epte
Key facts
| Inspection ID | 625848 |
|---|---|
| Firm | Amphastar France Pharmaceuticals |
| FEI number | 3003672088 |
| Address | Usine Saint Charles |
| City | Eragny Sur Epte |
| Country | France |
| Fiscal year | 2010 |
| Inspection end date | Oct 20, 2009 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data